Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive analysis of the expression profile and clinical implications of regulator of chromosome condensation 2 in pan-cancers. | Aging (Albany NY) | 2022 | 36441563 | PubTator, text mining | PubMed |
| A novel prognostic model for prostate cancer based on androgen biosynthetic and catabolic pathways. | Front Oncol | 2022 | 36439479 | PubTator, text mining | PubMed |
| Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer. | Front Immunol | 2022 | 36439090 | PubTator, text mining | PubMed |
| The role of costimulatory molecules in glioma biology and immune microenvironment. | Front Genet | 2022 | 36437961 | PubTator, text mining | PubMed |
| Characterization of glycosylation regulator-mediated glycosylation modification patterns and tumor microenvironment infiltration in hepatocellular carcinoma. | Front Genet | 2022 | 36437920 | PubTator, text mining | PubMed |
| Proteomics reveals unique identities of human TGF-β-induced and thymus-derived CD4+ regulatory T cells. | Sci Rep | 2022 | 36434024 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study. | Cells | 2022 | 36429070 | PubTator, text mining | PubMed |
| Regulatory T Cells in Ovarian Carcinogenesis and Future Therapeutic Opportunities. | Cancers (Basel) | 2022 | 36428581 | PubTator, text mining | PubMed |
| A deubiquitination module essential for Treg fitness in the tumor microenvironment. | Sci Adv | 2022 | 36427305 | PubTator, text mining | PubMed |
| CD4+CD25+ T regulatory cells in renal transplantation. | Front Immunol | 2022 | 36426347 | PubTator, text mining | PubMed |
| The Role of Dendritic Cells in the Host Response to Marek's Disease Virus (MDV) as Shown by Transcriptomic Analysis of Susceptible and Resistant Birds. | Pathogens | 2022 | 36422592 | PubTator, text mining | PubMed |
| Follicular regulatory T cells eliminate HIV-1-infected follicular helper T cells in an IL-2 concentration dependent manner. | Front Immunol | 2022 | 36420277 | PubTator, text mining | PubMed |
| Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA. | Oncol Lett | 2022 | 36420075 | PubTator, text mining | PubMed |
| High-level of intratumoral GITR+ CD4 T cells associate with poor prognosis in gastric cancer. | iScience | 2022 | 36419848 | PubTator, text mining | PubMed |
| A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators. | Front Genet | 2022 | 36406115 | PubTator, text mining | PubMed |
| Identifying hub genes of calcific aortic valve disease and revealing the immune infiltration landscape based on multiple WGCNA and single-cell sequence analysis. | Front Immunol | 2022 | 36405745 | PubTator, text mining | PubMed |
| A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. | Front Immunol | 2022 | 36405735 | PubTator, text mining | PubMed |
| The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy. | Front Immunol | 2022 | 36405727 | PubTator, text mining | PubMed |
| Regulation of hematopoietic and leukemia stem cells by regulatory T cells. | Front Immunol | 2022 | 36405718 | PubTator, text mining | PubMed |
| Potential impact of WTAP and YTHDF2 on tumor immunity in lung adenocarcinoma. | Medicine (Baltimore) | 2022 | 36397411 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=43